A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

Title
A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 1, Issue Suppl 1, Pages P259
Publisher
Springer Nature
Online
2013-11-07
DOI
10.1186/2051-1426-1-s1-p259

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now